Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  SoudjaSaï, Saïdi M ^a,b,c   Henri, Sandrine ^a,b,c   Mello, Marielle ^a,b,c   Chasson, Lionel ^a,b,c   Mas, Amandine ^a,b,c   Wehbe, Maria ^a,b,c   Auphan Anezin, Nathalie ^a,b,c   Leserman, Lee ^a,b,c   van den Eynde, Benoît ^d   Schmitt Verhulst, Anne Marie ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL INFILTRATION; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; INFLAMMATORY MELANOMA; LYMPH NODE; LYMPHOID ORGAN; MELANOMA; MOUSE; NONHUMAN; RETICULUM CELL; SKIN CELL; SPLEEN; STROMA CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD11B; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CHEMOKINE CCL21; DENDRITIC CELLS; FIBROBLASTS; INFLAMMATION; LYMPH NODES; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MYELOID CELLS; SKIN; SKIN NEOPLASMS; SPLEEN; STROMAL CELLS; T-LYMPHOCYTES;

MUS;

EID: 79960630266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022639     Document Type: Article

References (49)

1. Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW, (2002) Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 3: 265-271.
2. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, et al. (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406: 309-314.
3. Mempel TR, Henrickson SE, Von Andrian UH, (2004) T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427: 154-159.
4. Cyster JG, Ansel KM, Reif K, Ekland EH, Hyman PL, et al. (2000) Follicular stromal cells and lymphocyte homing to follicles. Immunol Rev 176: 181-193.
5. Cyster JG, (2003) Lymphoid organ development and cell migration. Immunol Rev 195: 5-14.
6. Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, et al. (2007) Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 8: 1255-1265.
7. Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, et al. (2006) Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25: 989-1001.
8. Bajenoff M, Glaichenhaus N, Germain RN, (2008) Fibroblastic reticular cells guide T lymphocyte entry into and migration within the splenic T cell zone. J Immunol 181: 3947-3954.
9. Steinman RM, Hawiger D, Nussenzweig MC, (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
10. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
11. Grivennikov SI, Greten FR, Karin M, (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
12. Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P, (2010) The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol 10: 554-567.
13. Gabrilovich D, (2004) Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4: 941-952.
14. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, et al. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 22: 238-244.
15. Gabrilovich DI, Nagaraj S, (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
16. Huijbers IJ, Krimpenfort P, Chomez P, van der Valk MA, Song JY, et al. (2006) An inducible mouse model of melanoma expressing a defined tumor antigen. Cancer Res 66: 3278-3286.
17. Soudja SM, Wehbe M, Mas A, Chasson L, de Tenbossche CP, et al. (2010) Tumor-initiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice. Cancer Res 70: 3515-3525.
18. Shanker A, Verdeil G, Buferne M, Inderberg-Suso EM, Puthier D, et al. (2007) CD8 T cell help for innate antitumor immunity. J Immunol 179: 6651-6662.
19. Ishida T, Oyama T, Carbone DP, Gabrilovich DI, (1998) Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. J Immunol 161: 4842-4851.
20. Henri S, Vremec D, Kamath A, Waithman J, Williams S, et al. (2001) The dendritic cell populations of mouse lymph nodes. J Immunol 167: 741-748.
21. Shortman K, Naik SH, (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7: 19-30.
22. Poulin LF, Henri S, de Bovis B, Devilard E, Kissenpfennig A, et al. (2007) The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 204: 3119-3131.
23. Henri S, Guilliams M, Poulin LF, Tamoutounour S, Ardouin L, et al. (2010) Disentangling the complexity of the skin dendritic cell network. Immunol Cell Biol 88: 366-375.
24. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, et al. (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21: 279-288.
25. Ginhoux F, Collin MP, Bogunovic M, Abel M, Leboeuf M, et al. (2007) Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 204: 3133-3146.
26. Villablanca EJ, Raccosta L, Zhou D, Fontana R, Maggioni D, et al. (2010) Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat Med 16: 98-105.
27. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, et al. (1999) Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189: 451-460.
28. Kraal G, Janse M, (1986) Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology 58: 665-669.
29. Mueller SN, Germain RN, (2009) Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 9: 618-629.
30. Van Vliet E, Melis M, Foidart JM, Van Ewijk W, (1986) Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody. J Histochem Cytochem 34: 883-890.
31. Farr AG, Berry ML, Kim A, Nelson AJ, Welch MP, et al. (1992) Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues. J Exp Med 176: 1477-1482.
32. Katakai T, Hara T, Sugai M, Gonda H, Shimizu A, (2004) Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med 200: 783-795.
33. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S, (2000) Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 192: 1425-1440.
34. Nolte MA, Belien JA, Schadee-Eestermans I, Jansen W, Unger WW, et al. (2003) A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp. J Exp Med 198: 505-512.
35. Chtanova T, Schaeffer M, Han SJ, van Dooren GG, Nollmann M, et al. (2008) Dynamics of neutrophil migration in lymph nodes during infection. Immunity 29: 487-496.
36. Zhao F, Falk C, Osen W, Kato M, Schadendorf D, et al. (2009) Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma. Clin Cancer Res 15: 4382-4390.
37. Boissonnas A, Scholer-Dahirel A, Simon-Blancal V, Pace L, Valet F, et al. (2010) Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 32: 266-278.
38. Britschgi MR, Favre S, Luther SA, (2010) CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19. Eur J Immunol 40: 1266-1271.
39. Carriere V, Colisson R, Jiguet-Jiglaire C, Bellard E, Bouche G, et al. (2005) Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node. Cancer Res 65: 11639-11648.
40. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, et al. (2004) CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 10: 2351-2358.
41. St John AL, Abraham SN, (2009) Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines. Nat Med 15: 1259-1265.
42. Mueller SN, Hosiawa-Meagher KA, Konieczny BT, Sullivan BM, Bachmann MF, et al. (2007) Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317: 670-674.
43. Xue Y, Religa P, Cao R, Hansen AJ, Lucchini F, et al. (2008) Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome. Proc Natl Acad Sci U S A 105: 18513-18518.
44. Hanson EM, Clements VK, Sinha P, Ilkovitch D, Ostrand-Rosenberg S, (2009) Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J Immunol 183: 937-944.
45. Gounaris E, Tung CH, Restaino C, Maehr R, Kohler R, et al. (2008) Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth. PLoS One 3: e2916.
46. Flaishon L, Hart G, Zelman E, Moussion C, Grabovsky V, et al. (2008) Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions. Blood 112: 5016-5025.
47. Hinrichs CS, Borman ZA, Cassard L, Gattinoni L, Spolski R, et al. (2009) Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc Natl Acad Sci U S A 106: 17469-17474.
48. Thompson ED, Enriquez HL, Fu YX, Engelhard VH, (2010) Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J Exp Med 207: 1791-1804.
49. Hamzah J, Jugold M, Kiessling F, Rigby P, Manzur M, et al. (2008) Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453: 410-414.